Associations between metabolic and aerobic fitness parameters in patients with schizophrenia

Journal of Nervous and Mental Disease

Volumn 203, Issue 1, 2015, Pages 23-27

  Vancampfort, Davy ^a,b   Guelinkcx, Hannes ^a   Probst, Michel ^a,b   Stubbs, Brendon ^c   Rosenbaum, Simon ^d,e,f,g   Ward, Philip B ^e,f   De Hert, Marc ^a,c  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b KU LEUVEN UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF GREENWICH   (United Kingdom)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e Schizophrenia Research Unit   (Australia)

^f GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^g UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Exercise; metabolic syndrome; physical activity; physical fitness; psychosis; schizophrenia

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; OXYGEN; TRIACYLGLYCEROL;

ADULT; AEROBIC CAPACITY; AEROBIC FITNESS; ARTICLE; ASTRAND RHYMING TEST; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EXERCISE TEST; FEMALE; FITNESS; GLUCOSE BLOOD LEVEL; HUMAN; LIFESTYLE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MAXIMAL OXYGEN UPTAKE; METABOLIC CAPACITY; METABOLIC FITNESS; METABOLIC SYNDROME X; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; SCHIZOPHRENIA; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; COMORBIDITY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADULT; COMORBIDITY; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OXYGEN CONSUMPTION; PHYSICAL FITNESS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84920840644     PISSN: 00223018     EISSN: 1539736X     Source Type: Journal    
DOI: 10.1097/NMD.0000000000000229     Document Type: Article

References (46)

1. Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome-A new world-wide definition. A consensus statement from the International Diabetes Federation. Diab Med. 23: 469-480.
2. American College of Sports Medicine (2013) ACSM's guidelines for exercise testing and prescription (9th ed) . Philadelphia, PA: Lippincott Williams & Wilkins.
3. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (5th ed) . Washington, DC: American Psychiatric Association.
4. Astrand I (1960) Aerobic work capacity in men and women with special reference to age. Acta Physiol Scand Suppl. 49: 1-92.
5. Blair SN, Cheng Y, Holder JS (2001) Is physical activity or physical fitness more important in defining health benefits? Med Sci Sports Exerc. 33: 379-399.
6. Bouchard C, Shepard R (1994) Physical activity, fitness, and health: The model and key concepts. In: Bouchard C, Shepard RJ, Stephens T (Eds) , Physical activity, fitness, and health. International proceedings and consensus statement (pp 77-88) . Champaign, IL: Human Kinetics.
7. Chance WW, Rhee C, Yilmaz C, Dane DM, Pruneda ML, Raskin P, Hsia CC (2008) Diminished alveolar microvascular reserves in type 2 diabetes reflect systemicmicroangiopathy. Diabetes Care. 31: 1596-1601.
8. Correll CU, Frederickson AM, Kane JM, Manu P (2006) Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs. J Clin Psychiatry. 67: 575-583.
9. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 35: 1381-1395.
10. De Hert M, Bussel J, Lindström E, Abrahams F, Franens C, Peuskens J (1998) PECC, psychosis evaluation tool for common use by caregivers. Antwerpen, Belgium: EPO.
11. De Hert M, Schreurs V, Vancampfort D, van Winkel R (2009) Metabolic syndrome in people with schizophrenia: A review. World Psychiatry. 8: 15-22.
12. De Hert M, Van Eyck D, Hanssens L, Peuskens H, Thys E, Wampers M, Scheen A, Peuskens J (2006) Oral glucose tolerance tests in treated patients with schizophrenia. Data to support an adaptation of the proposed guidelines for monitoring of patients on second generation antipsychotics? Eur Psychiatry. 21: 224-226.
13. De Hert M, Wampers M, Thys E, Wieselgren I, Lindström E, Peuskens J (2002) Validation study of PECC (Psychosis Evaluation tool for Common use by Caregivers): Interscale validity and inter-rater reliability. Int J Psychiatry Clin Pract. 6: 135-140.
14. Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N (2014) Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 105: 141-150.
15. Faulkner G, Cohn T, Remington G (2006) Validation of a physical activity assessment tool for individuals with schizophrenia. Schizophr Res. 82: 225-231.
16. Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ (2010) International consensus study of antipsychotic dosing. Am J Psychiatry. 167: 686-693.
17. Gill JM, Malkova D (1998) Physical activity, fitness and cardiovascular disease risk in adults: Interactions with insulin resistance and obesity. Clin Sci. 110: 409-425.
18. Huggins GS, Papandonatos GD, Erar B, Belalcazar LM, Brautbar A, Ballantyne C, Kitabchi AE, Wagenknecht LE, Knowler WC, Pownall HJ, Wing RR, Peter I, McCaffery JM; Genetics Subgroup of the Action for Health in Diabetes (Look AHEAD) Study. (2013) Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus? The Action for Health in Diabetes (Look AHEAD) study. Circ Cardiovasc Genet. 6: 391-399.
19. Izquierdo M, Ibanez J, Calbet JA, Navarro-Amezqueta I, González-Izal M, Idoate F, Häkkinen K, Kraemer WJ, Palacios-Sarrasqueta M, Almar M, Gorostiaga EM (2009) Cytokine and hormone responses to resistance training. Eur J Appl Physiol. 107: 397-409.
20. Jones TE, Basilio JL, Brophy PM, McCammon MR, Hickner RC (2009) Long-term exercise training in overweight adolescents improves plasma peptide YY and resistin. Obesity (Silver Spring) . 17: 1189-1195.
21. Manu P, Correll CU, Wampers M, Mitchell AJ, Probst M, Vancampfort D, De Hert M (2014) Markers of inflammation in schizophrenia: Association vs. causation. World Psychiatry. 13: 189-192.
22. Mitchell AJ, Malone D, Doebbeling CC (2009) Quality of medical care for people with and without comorbid mental illness and substance misuse: Systematic review of comparative studies. Br J Psychiatry. 194: 491-499.
23. Mitchell AJ, Vancampfort D, De Herdt A, Yu W, De Hert M (2013a) Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients. Schizophr Bull. 39: 295-305.
24. Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, Yu W, De Hert M (2013b) Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-A systematic review and meta-analysis. Schizophr Bull. 39: 306-318.
25. Nannipieri M, Bonotti A, Anselmino M, Cecchetti F, Madec S, Mancini E, Baldi S, Santini F, Pinchera A, Rossi M, Ferrannini E (2007) Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic state. Int J Obes (Lond) . 31: 1843-1848.
26. Ostermann S, Herbsleb M, Schulz S, et al. (2013) Exercise reveals the interrelation of physical fitness, inflammatory response, psychopathology, and autonomic function in patients with schizophrenia. Schizophr Bull. 39: 1139-1149.
27. Ozbulut O, GencA, Bagcioglu E, Coskun KS, Acar T, Alkoc OA, Karabacak H, Sener U, Ucok K (2013) Evaluation of physical fitness parameters in patients with schizophrenia. Psychiatry Res. 210: 806-811.
28. Pate RR (1988) The evolving definition of fitness. Quest. 40: 174-179.
29. Pérusse L, Gagnon J, Province MA, Rao DC, Wilmore JH, Leon AS, Bouchard C, Skinner JS (2001) Familial aggregation of submaximal aerobic performance in the HERITAGE family study. Med Sci Sports Exerc. 33: 597-604.
30. Steele RM, Brage S, Corder K, Wareham NJ, Ekelund U (2008) Physical activity, cardiorespiratory fitness, and the metabolic syndrome in youth. J Appl Physiol. 105: 342-351.
31. Strassnig MT, Brar JS, Ganguli R (2011) Low cardiorespiratory fitness and physical functional capacity in obese patients with schizophrenia. Schizophr Res. 126: 103-109.
32. Strassnig MT, Newcomer JW, Harvey PD (2012) Exercise improves physical capacity in obese patients with schizophrenia: Pilot study. Schizophr Res. 141: 284-285.
33. Surwillo W (1980) Experimental design in psychiatry. Research methods for clinical practice. New York: Grune and Stratton.
34. Vancampfort D, Guelinckx H, De Hert M, Stubbs B, Soundy A, Rosenbaum S, De Schepper E, Probst M (2014a) Reliability and clinical correlates of the Astrand- Rhyming sub-maximal exercise test in patients with schizophrenia or schizoaffective disorder. Psychiatry Res. doi: 10.1016/j.psychres.2014.08.049. [Epub ahead of print].
35. Vancampfort D, Knapen J, Probst M, vanWinkel R, Deckx S, Maurissen K, Peuskens J, De Hert M (2010) Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia. Psychiatry Res. 177: 271-279.
36. Vancampfort D, Probst M, Knapen J, Carraro A, De Hert M (2012) Associations between sedentary behaviour and metabolic parameters in patients with schizophrenia. Psychiatry Res. 200: 73-78.
37. Vancampfort D, Probst M, Scheewe TW, De Herdt A, Sweers K, Knapen J, van Winkel R, De Hert M (2013b) Relationships between physical fitness, physical activity, smoking and metabolic and mental health parameters in people with schizophrenia. Psychiatry Res. 207: 25-32.
38. Vancampfort D, Probst M, Stubbs B, Soundy A, De Herdt A, De Hert M (2014b) Associations between expiratory spirometry parameters and limitations in daily life activities in patients with schizophrenia. Gen Hosp Psychiatry. 36: 172-176.
39. Vancampfort D, Probst M, Stubbs B, Soundy A, De Herdt A, De Hert M (2014c) Metabolic syndrome and lung function in schizophrenia: A pilot study. Psychiatry Res. doi: 10.1016/j.psychres.2014.06.008.
40. Vancampfort D, Sweers K, Probst M, Maurissen K, Knapen J, Minguet P, De Hert M (2011) Association of the metabolic syndrome with physical activity performance in patients with schizophrenia. Diabetes Metab. 37: 318-323.
41. Vancampfort D, Wampers M, Mitchell AJ, Correll CU, De Herdt A, Probst M, DeHert M (2013a) A meta-analysis of cardio-metabolic abnormalities in drug naïve, firstepisode and multi-episode patients with schizophrenia versus general population controls. World Psychiatry. 12: 240-250.
42. Vanhees L, Lefevre J, Philippaerts R, Martens M, Huygens W, Troosters T, Beunen G (2005) How to assess physical activity? How to assess physical fitness? Eur J Cardiovasc Prev Rehabil. 12: 102-114.
43. vanWinkel R, DeHert M, Van Eyck D, Hanssens L,Wampers M, Scheen A, Peuskens J (2006) Screening for diabetes and other metabolic abnormalities in patients with schizophrenia and schizoaffective disorder: Evaluation of incidence and screening methods. J Clin Psychiatry. 67: 1493-1500.
44. Wang X, BaoW, Liu J, Ouyang YY, Wang D, Rong S, Xiao X, Shan ZL, Zhang Y, Yao P, Liu LG (2013) Inflammatory markers and risk of type 2 diabetes: A systematic review and meta-analysis. Diabetes Care. 36: 166-175.
45. Wei M, Kampert JB, Barlow CE, Nichaman MZ, Gibbons LW, Paffenbarger RS Jr, Blair SN (1999) Relationship between low cardiorespiratory fitness and mortality in normal weight, overweight, and obese men. JAMA. 282: 1547-1553.
46. Welty FK (2013) How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis? Curr Cardiol Rep. 15: 400.